DEVICE CATEGORY · SHC
Low Electric Field Generator For Pancreatic Cancer Treatment
Intended to treat pancreatic cancer through delivery of low electric fields in patients receiving concomitant systemic therapies or other standard of care treatment(s)
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Optune PaxP250034/S004 | Novocure, GmbH | PMA supplement | Oct 26, 2026 | FDA |
Optune PaxP250034/S001 | Novocure, GmbH | PMA supplement | Jul 1, 2026 | FDA |
Optune PaxP250034 | Novocure, GmbH | PMA approval | Feb 11, 2026 | FDA |
Source information
Follow the FDA links to view the original records.

